AI-assisted, human-published
10/19/2026 /Funding Events
Estuary Biotherapeutics Secures $103 Million Financing to Advance Genetic Medicines for Kidney Diseases
A $93M Series A led by RA Capital Management, with strategic investors across biotech and kidney disease, supports Estuary Biotherapeutics’ launch and growth.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com